The company's lead drug candidate includes UBX1325, which is phase II clinical trial for the treatment of age-related diseases. According to present data UBIX.Network ( UBX ) and potentially its market environment has been in bearish cycle last 12 months (if exists). Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. Cryptocurrency Market & Coin Exchange report, prediction for the future: Youll find the UBIX.Network Price prediction below. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. UBX : Unity Biotechnology stock forecast by Wall Street Analysts The average Unity Biotechnology stock forecast from last 6 month is 7.6, and this show a 0. was incorporated in 2009 and is headquartered in South San Francisco, California. A high-level overview of Unity Biotechnology, Inc. The average Unity Biotechnology stock price prediction forecasts a potential upside of 231.75 from the current UBX share price of 2.11. Min Forecast 2.00 -5.21 Avg Forecast 7.00 +231.75 Max Forecast 10. On average, Wall Street analysts predict that Unity Biotechnology's share price could reach 7.00 by Nov 14, 2024. , (UBX) Latest Stock News., (UNIT) Stock Price, Quote & News., (PATH) Stock. Top Analysts Based on 4 analyst s offering 12 month price targets for Unity Biotechnology Inc. The best long-term & short-term Unity Biotechnology share price. and changed its name to Unity Biotechnology, Inc. (UNIT) stock analyst estimates, including earnings and revenue, EPS. Unity Biotechnology Stock Forecast, UBX stock price prediction. Analysts estimate an earnings decrease this quarter of 0.43 per share, a decrease next quarter of 0.00 per share. Get the latest United States Steel Corporation X detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The average Unity Biotechnology stock forecast 2023 represents a -15.32 decrease from the last price of 4.80000019073486. Unity Biotechnology Forecast Revenue Growth. View United States Steel Corporation X investment & stock information. The company was formerly known as Forge, Inc. For Unity Biotechnology stock forecast for 2023, 10 predictions are offered for each month of 2023 with average Unity Biotechnology stock forecast of 4.06, a high forecast of 4.59, and a low forecast of 3.69. It also develops UBX1967 for the treatment of ophthalmologic diseases UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company's lead drug candidate includes UBX1325, which is phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. Recently underwent a 10-to-1 reverse stock split to maintain a minimum price required for NASDAQ. They acquired a dozen companies after their IPO in 2007, after acquiring connectblue in 2014 and Lesswire in 2015 they acquired Rigado's module business in 2019.Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. All these products enable the delivery of complete systems for location-based services and M2M applications in the Internet of Things, that rely on the convergence of 2G/3G/4G, Bluetooth-, Wi-Fi technology and satellite navigation. On average, analysts rate UBX stock stock as a strong buy. The lowest target is 6.00 and the highest is 10. The wireless range consists of GSM-, UMTS- and CDMA2000 and LTE modules, as well as Bluetooth- and WiFi-modules. According to 5 stock analysts, the average 12-month stock price forecast for UBX stock stock is 8.40, which predicts an increase of 294.37. U-blox develops and sells chips and modules that support global navigation satellite systems, including receivers for GPS, GLONASS, Galileo, BeiDou and QZSS. The company is listed at the Swiss Stock Exchange and has offices in the US, Singapore, China, Taiwan, Korea, Japan, India, Pakistan, Australia, Ireland, the UK, Belgium, Germany, Sweden, Finland, Italy and Greece. What is the current Price Target and Forecast for UNITY Biotechnology (UBX) UNITY Biotechnology (UBX) (Delayed Data from NSDQ) 2.13 USD +0.32 (17.68) Updated 04:00 PM ET. U-blox is a spin-off of the Swiss Federal Institute of Technology in Zurich and was founded in 1997 and is headquartered in Thalwil, Switzerland. They operate as a fabless IC and design house. U-blox is a Swiss company that creates wireless semiconductors and modules for consumer, automotive and industrial markets.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |